MICHAEL TACCONA: Open Payments
NPI 1861223570 · LISLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,619 in 72 payments from 21 companies in 2025. Trend: 2023 $0 · 2024 $719 · 2025 $2,619
Food & beverage: $2,034Consulting: $500Education: $85
| Company | Payments | Amount |
|---|---|---|
| AngioDynamics, Inc. | 10 | $663 |
| AstraZeneca Pharmaceuticals LP | 1 | $500 |
| Janssen Biotech, Inc. | 8 | $232 |
| TOLMAR, INC. | 8 | $147 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $147 |
| Astellas Pharma US Inc | 5 | $130 |
| UROGEN PHARMA, INC. | 5 | $126 |
| Ferring Pharmaceuticals Inc. | 1 | $93 |
| ABBVIE INC. | 5 | $79 |
| PROGENICS PHARMACEUTICALS, INC. | 3 | $75 |
Products named: NANOKNIFE, IMFINZI, ERLEADA, Nubeqa, Xtandi, ELIGARD, ADSTILADRIN, LUPRON DEPOT.
Industry payments across IL — which companies pay providers there.
